We are live on ! Find out more
CRL icon

Charles River Laboratories
CRL

612 hedge funds and large institutions have $10.7B invested in Charles River Laboratories in 2023 Q2 according to their latest regulatory filings, with 67 funds opening new positions, 252 increasing their positions, 203 reducing their positions, and 73 closing their positions.

New
Increased
Maintained
Reduced
Closed

24% more repeat investments, than reductions

Existing positions increased: 252 | Existing positions reduced: 203

5% more capital invested

Capital invested by funds: $10.3B → $10.7B (+$474M)

0.21% less ownership

Funds ownership: 100.16% → 99.94% (-0.21%)

8% less first-time investments, than exits

New positions opened: 67 | Existing positions closed: 73

1% less funds holding

Funds holding: 620 → 612 (-8)

16% less call options, than puts

Call options by funds: $29.3M | Put options by funds: $34.8M

17% less funds holding in top 10

Funds holding in top 10: 6 → 5 (-1)

Holders
612
Holders Change
-8
Holders Change %
-1.29%
% of All Funds
9.61%
Holding in Top 10
5
Holding in Top 10 Change
-1
Holding in Top 10 Change %
-16.67%
% of All Funds
0.08%
New
67
Increased
252
Reduced
203
Closed
73
Calls
$29.3M
Puts
$34.8M
Net Calls
-$5.51M
Net Calls Change
-$16.3M

Top Buyers

1
BlackRock
BlackRock
New York
+$81.8M
2
AI
Ariel Investments
Illinois
+$72.6M
3
ClearBridge Investments
ClearBridge Investments
New York
+$68.3M
4
Point72 Asset Management
Point72 Asset Management
Connecticut
+$50.8M
5
MBI
Montrusco Bolton Investments
Quebec, Canada
+$43.7M

Top Sellers

1
Marshall Wace
Marshall Wace
United Kingdom
-$105M
2
Viking Global Investors
Viking Global Investors
Connecticut
-$79.5M
3
JSP
Jackson Square Partners
California
-$62.2M
4
William Blair Investment Management
William Blair Investment Management
Illinois
-$60M
5
FAM
Fred Alger Management
New York
-$44.1M
Name Holding Trade Value Shares
Change 		Change in
Stake
RCM
626
Rivermont Capital Management
New York
– -$3.95M -19,565 Closed
EAM
627
EULAV Asset Management
Florida
– -$3.43M -17,000 Closed
D.E. Shaw & Co
628
D.E. Shaw & Co
New York
– -$2.43M -12,022 Closed
CIP
629
Capital Insight Partners
Arizona
– -$2.27M -11,239 Closed
IG
630
ING Group
Netherlands
– -$1.74M -8,646 Closed
FC
631
FORA Capital
Florida
– -$1.64M -8,143 Closed
CANY
632
Caxton Associates (New York)
New York
– -$1.61M -7,976 Closed
FGI
633
Foresight Global Investors
New York
– -$1.19M -5,885 Closed
CAM
634
ClariVest Asset Management
California
– -$961K -4,755 Closed
N
635
Natixis
France
– -$953K -4,722 Closed
BFM
636
Boothbay Fund Management
New York
– -$877K -4,346 Closed
FRM
637
Fox Run Management
Connecticut
– -$872K -4,320 Closed
WBC
638
Westpac Banking Corp
Australia
– -$868K -4,303 Closed
EIM
639
Essex Investment Management
Massachusetts
– -$847K -4,198 Closed
LOAME
640
Lombard Odier Asset Management (Europe)
United Kingdom
– -$767K -3,800 Closed
KF
641
Krilogy Financial
Missouri
– -$632K -3,131 Closed
IIM
642
INTECH Investment Management
Florida
– -$584K -2,893 Closed
CS
643
Candriam SCA
Luxembourg
– -$532K -2,866 Closed
DTL
644
Dynamic Technology Lab
Singapore
– -$534K -2,648 Closed
ESCM
645
Echo Street Capital Management
New York
– -$525K -2,599 Closed
IMRF
646
Illinois Municipal Retirement Fund
Illinois
– -$513K -2,544 Closed
NFC
647
Northeast Financial Consultants
Connecticut
– -$418K -2,073 Closed
SAM
648
Simplify Asset Management
Nevada
– -$399K -1,977 Closed
Holocene Advisors
649
Holocene Advisors
New York
– -$369K -1,830 Closed
BC
650
Bridgefront Capital
Texas
– -$369K -1,826 Closed
24 25
26
27 28

CRL Hedge Fund Activity: Q2 2023 in Review

612 of the 6,369 institutional investors tracked by Wall St. Rank reported a position in Charles River Laboratories (CRL) for Q2 2023, worth a combined $10.7B — up 4.6% from $10.3B a quarter earlier.

Sellers outnumbered buyers: 73 funds closed out of CRL and 67 opened new positions — a net loss of 6 holders — while 203 trimmed existing stakes and 252 added.

The largest buyer was BlackRock, adding an estimated $81.8M. The largest seller was Marshall Wace, cutting an estimated $105M.

  • 612 institutional investors held Charles River Laboratories (CRL) as of Q2 2023, down from 620 in Q1 2023.
  • Funds reported $10.7B of Charles River Laboratories stock for Q2 2023, up 4.6% quarter-over-quarter.
  • 67 funds opened new Charles River Laboratories positions in Q2 2023 and 73 closed out, a net change of -6 holders.
  • The largest Charles River Laboratories buyer in Q2 2023 was BlackRock, an estimated $81.8M added.
  • The largest Charles River Laboratories seller in Q2 2023 was Marshall Wace, an estimated $105M sold.

Based on aggregated 13F filings for Q2 2023.